Constructing an Intelligent Model Based on Support Vector Regression to Simulate the Solubility of Drugs in Polymeric Media

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Nov 24

PMID 36422535

Authors

Sait Senceroglu

Mohamed Arselene Ayari

Tahereh Rezaei

Fardad Faress

Amith Khandakar

Muhammad E H Chowdhury

Zanko Hassan Jawhar

Affiliations

Soon will be listed here.

Abstract

This study constructs a machine learning method to simultaneously analyze the thermodynamic behavior of many polymer-drug systems. The solubility temperature of Acetaminophen, Celecoxib, Chloramphenicol, D-Mannitol, Felodipine, Ibuprofen, Ibuprofen Sodium, Indomethacin, Itraconazole, Naproxen, Nifedipine, Paracetamol, Sulfadiazine, Sulfadimidine, Sulfamerazine, and Sulfathiazole in 1,3-bis[2-pyrrolidone-1-yl] butane, Polyvinyl Acetate, Polyvinylpyrrolidone (PVP), PVP K12, PVP K15, PVP K17, PVP K25, PVP/VA, PVP/VA 335, PVP/VA 535, PVP/VA 635, PVP/VA 735, Soluplus analyzes from a modeling perspective. The least-squares support vector regression (LS-SVR) designs to approximate the solubility temperature of drugs in polymers from polymer and drug types and drug loading in polymers. The structure of this machine learning model is well-tuned by conducting trial and error on the kernel type (i.e., Gaussian, polynomial, and linear) and methods used for adjusting the LS-SVR coefficients (i.e., leave-one-out and 10-fold cross-validation scenarios). Results of the sensitivity analysis showed that the Gaussian kernel and 10-fold cross-validation is the best candidate for developing an LS-SVR for the given task. The built model yielded results consistent with 278 experimental samples reported in the literature. Indeed, the mean absolute relative deviation percent of 8.35 and 7.25 is achieved in the training and testing stages, respectively. The performance on the largest available dataset confirms its applicability. Such a reliable tool is essential for monitoring polymer-drug systems' stability and deliverability, especially for poorly soluble drugs in polymers, which can be further validated by adopting it to an actual implementation in the future.

References

Knopp M, Tajber L, Tian Y, Olesen N, Jones D, Kozyra A . Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility. Mol Pharm. 2015; 12(9):3408-19. DOI: 10.1021/acs.molpharmaceut.5b00423. View

Sun Y, Tao J, Zhang G, Yu L . Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. J Pharm Sci. 2010; 99(9):4023-31. DOI: 10.1002/jps.22251. View

Wang X, Xu S, Zhou X, Zhao R, Lin Y, Cao J . Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk. Nat Commun. 2021; 12(1):3428. PMC: 8187647. DOI: 10.1038/s41467-021-23827-0. View

Zheng J, Long X, Chen H, Ji Z, Shu B, Yue R . Photoclick Reaction Constructs Glutathione-Responsive Theranostic System for Anti-Tuberculosis. Front Mol Biosci. 2022; 9:845179. PMC: 8883117. DOI: 10.3389/fmolb.2022.845179. View

Tao J, Sun Y, Zhang G, Yu L . Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. Pharm Res. 2008; 26(4):855-64. DOI: 10.1007/s11095-008-9784-z. View

Newman A, Nagapudi K, Wenslow R . Amorphous solid dispersions: a robust platform to address bioavailability challenges. Ther Deliv. 2015; 6(2):247-61. DOI: 10.4155/tde.14.101. View

Yang W, Liu W, Li X, Yan J, He W . Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2. J Adv Res. 2022; 45:59-71. PMC: 10006529. DOI: 10.1016/j.jare.2022.05.009. View

Song K, Wu D . Shared decision-making in the management of patients with inflammatory bowel disease. World J Gastroenterol. 2022; 28(26):3092-3100. PMC: 9331519. DOI: 10.3748/wjg.v28.i26.3092. View

Mamidi H, Rohera B . Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug. J Pharm Sci. 2021; 110(7):2703-2717. DOI: 10.1016/j.xphs.2021.01.036. View

10.

Wang D, Wang F, Shi K, Tao H, Li Y, Zhao R . Lower Circulating Folate Induced by a Fidgetin Intronic Variant Is Associated With Reduced Congenital Heart Disease Susceptibility. Circulation. 2017; 135(18):1733-1748. DOI: 10.1161/CIRCULATIONAHA.116.025164. View

11.

Meng F, Trivino A, Prasad D, Chauhan H . Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. Eur J Pharm Sci. 2015; 71:12-24. DOI: 10.1016/j.ejps.2015.02.003. View

12.

. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today Technol. 2013; 9(2):e71-e174. DOI: 10.1016/j.ddtec.2011.10.002. View

13.

Knopp M, Gannon N, Porsch I, Rask M, Olesen N, Langguth P . A Promising New Method to Estimate Drug-Polymer Solubility at Room Temperature. J Pharm Sci. 2016; 105(9):2621-2624. DOI: 10.1016/j.xphs.2016.02.017. View

14.

Knopp M, Olesen N, Holm P, Lobmann K, Holm R, Langguth P . Evaluation of drug-polymer solubility curves through formal statistical analysis: comparison of preparation techniques. J Pharm Sci. 2014; 104(1):44-51. DOI: 10.1002/jps.24207. View

15.

Wang J, Ayari M, Khandakar A, Chowdhury M, Uz Zaman S, Rahman T . Estimating the Relative Crystallinity of Biodegradable Polylactic Acid and Polyglycolide Polymer Composites by Machine Learning Methodologies. Polymers (Basel). 2022; 14(3). PMC: 8840207. DOI: 10.3390/polym14030527. View

16.

Schittny A, Huwyler J, Puchkov M . Mechanisms of increased bioavailability through amorphous solid dispersions: a review. Drug Deliv. 2019; 27(1):110-127. PMC: 6968646. DOI: 10.1080/10717544.2019.1704940. View

17.

Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M . Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction. Pharm Res. 2016; 33(10):2445-58. DOI: 10.1007/s11095-016-1969-2. View

18.

Kyeremateng S, Pudlas M, Woehrle G . A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations. J Pharm Sci. 2014; 103(9):2847-2858. DOI: 10.1002/jps.23941. View

19.

Asgreen C, Knopp M, Skytte J, Lobmann K . Influence of the Polymer Glass Transition Temperature and Molecular Weight on Drug Amorphization Kinetics Using Ball Milling. Pharmaceutics. 2020; 12(6). PMC: 7355600. DOI: 10.3390/pharmaceutics12060483. View

20.

Lai W, Tang R, Wong W . Ionically Crosslinked Complex Gels Loaded with Oleic Acid-Containing Vesicles for Transdermal Drug Delivery. Pharmaceutics. 2020; 12(8). PMC: 7465615. DOI: 10.3390/pharmaceutics12080725. View